Search

Your search keyword '"Nyberg, L."' showing total 42 results

Search Constraints

Start Over You searched for: Author "Nyberg, L." Remove constraint Author: "Nyberg, L." Publisher elsevier Remove constraint Publisher: elsevier
42 results on '"Nyberg, L."'

Search Results

1. Lifestyle-related risk factors and their cumulative associations with hippocampal and total grey matter volume across the adult lifespan: a pooled analysis in the European Lifebrain consortium

3. Factors influencing renal function in patients receiving telaprevir twice daily or every 8 hours: Results from the phase III optimize study.

4. Efficacy of telaprevir dosed twice daily versus every 8 hours by IL28B genotype: Results from the phase iii optimize study.

5. Adherence with telaprevir BID vs. q8h dosing in treatment-naive HCV-infected patients: Results from the phase III optimize study.

6. Anemia and its management in patients treated with telaprevir twice daily versus every 8 hours in the phase III optimize study.

7. OPTIMIZE trial: Non-inferiority of twice-daily telaprevir versus administration every 8 hours in treatment-naive, genotype 1 HCV infected patients.

8. Safety and efficacy of twice daily versus every 8 hour telaprevir with peginterferon/ribavirin (PR) in patients with cirrhosis.

10. Impact of extreme weather events on mental health in South and Southeast Asia: A two decades of systematic review of observational studies.

11. Longitudinal support for the correlative triad among aging, dopamine D2-like receptor loss, and memory decline.

12. Beyond the Global Brain Differences: Intraindividual Variability Differences in 1q21.1 Distal and 15q11.2 BP1-BP2 Deletion Carriers.

14. No moderating influence of education on the association between changes in hippocampus volume and memory performance in aging.

15. Longitudinal change-change associations of cognition with cortical thickness and surface area.

16. Improvement of cognition across a decade after stroke correlates with the integrity of functional brain networks.

17. Model of brain maintenance reveals specific change-change association between medial-temporal lobe integrity and episodic memory.

18. Associations of depression and regional brain structure across the adult lifespan: Pooled analyses of six population-based and two clinical cohort studies in the European Lifebrain consortium.

19. Sex differences in dopamine integrity and brain structure among healthy older adults: Relationships to episodic memory.

20. Increased functional homotopy of the prefrontal cortex is associated with corpus callosum degeneration and working memory decline.

21. Forecasting memory function in aging: pattern-completion ability and hippocampal activity relate to visuospatial functioning over 25 years.

22. Neurocognitive processes underlying heuristic and normative probability judgments.

23. Maintained memory in aging is associated with young epigenetic age.

24. A genetic association study of CSMD1 and CSMD2 with cognitive function.

25. Longitudinal association between hippocampus atrophy and episodic-memory decline.

26. White matter integrity as a marker for cognitive plasticity in aging.

27. Midlife memory ability accounts for brain activity differences in healthy aging.

28. Longitudinal assessment of default-mode brain function in aging.

29. Local brain atrophy accounts for functional activity differences in normal aging.

30. APOE ε4 is associated with longer telomeres, and longer telomeres among ε4 carriers predicts worse episodic memory.

31. Dopamine D(1) receptors and age differences in brain activation during working memory.

32. Effects of method of translation of patient-reported health outcome questionnaires: a randomized study of the translation of the Rheumatoid Arthritis Quality of Life (RAQoL) Instrument for Sweden.

33. Simulating neurocognitive aging: effects of a dopaminergic antagonist on brain activity during working memory.

34. Sphingolipids in human ileostomy content after meals containing milk sphingomyelin.

35. Controversies in the management of vesicoureteral reflux: the rationale for the RIVUR study.

36. Challenging the notion of an early-onset of cognitive decline.

37. A phase I trial of an antisense inhibitor of hepatitis C virus (ISIS 14803), administered to chronic hepatitis C patients.

38. Altered brain activity in healthy seniors: what does it mean?

39. Predisposing and precipitating factors for falls among older people in residential care.

42. Bioavailability of digoxin.

Catalog

Books, media, physical & digital resources